EFFECT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS ON DEVELOPMENT OF CIRRHOSIS IN PATIENTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Sobotka, Lindsay [1 ]
Ramsey, Mitchell L. [1 ]
Porter, Kyle [2 ]
Lara, Luis F. [1 ]
Wellner, Michael [3 ]
机构：
[1] Ohio State Wexner Med Ctr, Gastroenterol Hepatol & Nutr, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA
[3] Ohio State Univ, Wexner Med Ctr, Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
592
引用
收藏
页码：356A / 357A
页数：2
相关论文
共 50 条
  • [1] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Ramsey, Mitchell L.
    Wellner, Michael R.
    Porter, Kyle
    Kirkby, Stephen E.
    Li, Susan S.
    Lara, Luis F.
    Kelly, Sean G.
    Hanje, A. James
    Sobotka, Lindsay A.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 411 - 419
  • [2] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Mitchell L Ramsey
    Michael R Wellner
    Kyle Porter
    Stephen E Kirkby
    Susan S Li
    Luis F Lara
    Sean G Kelly
    A James Hanje
    Lindsay A Sobotka
    [J]. World Journal of Hepatology, 2022, (02) : 411 - 419
  • [3] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [4] Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
    Burgener, Elizabeth B.
    Moss, Richard B.
    [J]. CURRENT OPINION IN PEDIATRICS, 2018, 30 (03) : 372 - 377
  • [5] Tritherapy with cystic fibrosis transmembrane conductance regulator protein modulators in cystic fibrosis
    Colodro, Oscar Fielbaum
    Grell, Alberto Vidal
    Yarur, Alejandra Mendez
    Clerc, Camila Sobarzo
    [J]. ANDES PEDIATRICA, 2022, 93 (06): : 898 - 905
  • [6] Cystic fibrosis transmembrane conductance regulator modulators for cystic fibrosis: a new dawn?
    Edmondson, Claire
    Course, Christopher William
    Doull, Iolo
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (10) : 941 - 945
  • [7] Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
    Schmidt, BeLa Z.
    Haaf, Jeremy B.
    Leal, Teresinha
    Noel, Sabrina
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 127 - 140
  • [8] Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators
    Vargas-Roldan, Silvia Y.
    Lezana-Fernandez, Jose L.
    Cerna-Cortes, Jorge F.
    Partida-Sanchez, Santiago
    Santos-Preciado, Jose, I
    Rosales-Reyes, Roberto
    [J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (04): : 215 - 221
  • [9] Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
    Derichs, Nico
    [J]. EUROPEAN RESPIRATORY REVIEW, 2013, 22 (127): : 58 - 65
  • [10] Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
    Manioudaki, Sofia
    Vasilieva, Larisa
    Mani, Ilianna
    Diamantea, Filia
    Alexopoulos, Theodoros
    Pouriki, Sophia
    Athanassa, Zoe
    Sakagianni, Aikaterini
    Geladari, Eleni
    Elefsiniotis, Ioannis
    Hadziyannis, Emilia
    Alexopoulou, Alexandra
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S978 - S979
12345